After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Kymera Therapeutics Inc is $2.18B. A total of 0.61 million shares were traded on the day, compared to an average of 700.51K shares.
In the most recent transaction, Chiniara Ellen sold 2,241 shares of KYMR for 30.45 per share on Mar 03 ’25. After the transaction, the Chief Legal Officer now owns 80,085 company shares. In a previous transaction on Mar 03 ’25, Chadwick Jeremy G sold 1,383 shares at 30.45 per share. KYMR shares that Chief Operating Officer owns now total 67,800.
Among the insiders who sold shares, Jacobs Bruce N. disposed of 7,035 shares on Mar 03 ’25 at a per-share price of $30.45. This resulted in the Chief Financial Officer holding 201,886 shares of KYMR after the transaction. In another insider transaction, Gollob Jared sold 5,740 shares at $30.45 per share on Mar 03 ’25. Company shares held by the Chief Medical Officer now total 120,000.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, KYMR has a high of $53.27 and a low of $19.44.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. KYMR’s latest balance sheet shows that the firm has $442.42M in Cash & Short Term Investments as of fiscal 2021. There were $17.96M in debt and $92.54M in liabilities at the time. Its Book Value Per Share was $12.88, while its Total Shareholder’s Equity was $459.64M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KYMR is Buy with a score of 4.60.
